Viewing StudyNCT00118768



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00118768
Status: COMPLETED
Last Update Posted: 2009-03-02
First Post: 2005-06-30

Brief Title: A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-08
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2005-06-30
First Submit QC Date: July 8 2005
Study First Post Date: 2005-07-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2009-02-27
Last Update Post Date: 2009-03-02
Last Update Post Date Type: ESTIMATED